nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefadroxil—SLC22A6—Hydrochlorothiazide—nephrolithiasis	0.56	1	CbGbCtD
Cefadroxil—SLC22A8—Organic anion transport—SLC22A12—nephrolithiasis	0.031	0.105	CbGpPWpGaD
Cefadroxil—SLC22A6—Organic anion transport—SLC22A12—nephrolithiasis	0.0259	0.0874	CbGpPWpGaD
Cefadroxil—SLC22A8—nephron—nephrolithiasis	0.0168	0.186	CbGeAlD
Cefadroxil—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.016	0.0539	CbGpPWpGaD
Cefadroxil—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0144	0.0487	CbGpPWpGaD
Cefadroxil—SLC22A8—urine—nephrolithiasis	0.0135	0.149	CbGeAlD
Cefadroxil—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A12—nephrolithiasis	0.0121	0.0407	CbGpPWpGaD
Cefadroxil—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC3A1—nephrolithiasis	0.00799	0.027	CbGpPWpGaD
Cefadroxil—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC3A1—nephrolithiasis	0.00742	0.025	CbGpPWpGaD
Cefadroxil—SLC22A6—nephron tubule—nephrolithiasis	0.00605	0.0671	CbGeAlD
Cefadroxil—SLC22A6—cortex of kidney—nephrolithiasis	0.00518	0.0575	CbGeAlD
Cefadroxil—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.00514	0.0174	CbGpPWpGaD
Cefadroxil—SLC15A1—nephron tubule—nephrolithiasis	0.00503	0.0559	CbGeAlD
Cefadroxil—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC7A9—nephrolithiasis	0.00502	0.0169	CbGpPWpGaD
Cefadroxil—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A6—nephrolithiasis	0.00477	0.0161	CbGpPWpGaD
Cefadroxil—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.0047	0.0159	CbGpPWpGaD
Cefadroxil—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.0047	0.0159	CbGpPWpGaD
Cefadroxil—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC7A9—nephrolithiasis	0.00466	0.0157	CbGpPWpGaD
Cefadroxil—SLC15A1—renal system—nephrolithiasis	0.00458	0.0508	CbGeAlD
Cefadroxil—SLC15A1—kidney—nephrolithiasis	0.00442	0.0491	CbGeAlD
Cefadroxil—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC3A1—nephrolithiasis	0.00437	0.0147	CbGpPWpGaD
Cefadroxil—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A3—nephrolithiasis	0.00437	0.0147	CbGpPWpGaD
Cefadroxil—SLC22A8—nephron tubule—nephrolithiasis	0.00362	0.0402	CbGeAlD
Cefadroxil—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.00357	0.012	CbGpPWpGaD
Cefadroxil—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.00331	0.0112	CbGpPWpGaD
Cefadroxil—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC34A1—nephrolithiasis	0.00331	0.0112	CbGpPWpGaD
Cefadroxil—SLC22A8—renal system—nephrolithiasis	0.00329	0.0365	CbGeAlD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.0032	0.0108	CbGpPWpGaD
Cefadroxil—SLC22A8—kidney—nephrolithiasis	0.00318	0.0353	CbGeAlD
Cefadroxil—SLC15A2—nephron tubule—nephrolithiasis	0.00315	0.0349	CbGeAlD
Cefadroxil—SLC22A8—cortex of kidney—nephrolithiasis	0.0031	0.0344	CbGeAlD
Cefadroxil—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC26A1—nephrolithiasis	0.00308	0.0104	CbGpPWpGaD
Cefadroxil—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00307	0.0571	CcSEcCtD
Cefadroxil—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00305	0.0568	CcSEcCtD
Cefadroxil—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00298	0.01	CbGpPWpGaD
Cefadroxil—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.00295	0.00997	CbGpPWpGaD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00289	0.00976	CbGpPWpGaD
Cefadroxil—SLC15A2—renal system—nephrolithiasis	0.00286	0.0317	CbGeAlD
Cefadroxil—SLC15A2—kidney—nephrolithiasis	0.00277	0.0307	CbGeAlD
Cefadroxil—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC7A9—nephrolithiasis	0.00274	0.00925	CbGpPWpGaD
Cefadroxil—SLC22A5—nephron tubule—nephrolithiasis	0.00274	0.0304	CbGeAlD
Cefadroxil—SLC15A2—cortex of kidney—nephrolithiasis	0.00269	0.0299	CbGeAlD
Cefadroxil—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00269	0.00908	CbGpPWpGaD
Cefadroxil—Swelling—Hydrochlorothiazide—nephrolithiasis	0.00268	0.0498	CcSEcCtD
Cefadroxil—Haemolytic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00261	0.0486	CcSEcCtD
Cefadroxil—SLC22A5—renal system—nephrolithiasis	0.00249	0.0276	CbGeAlD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A12—nephrolithiasis	0.00242	0.00815	CbGpPWpGaD
Cefadroxil—SLC22A5—kidney—nephrolithiasis	0.00241	0.0267	CbGeAlD
Cefadroxil—SLC22A5—cortex of kidney—nephrolithiasis	0.00234	0.026	CbGeAlD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0023	0.00775	CbGpPWpGaD
Cefadroxil—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A9—nephrolithiasis	0.00225	0.00758	CbGpPWpGaD
Cefadroxil—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00221	0.0411	CcSEcCtD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00213	0.0072	CbGpPWpGaD
Cefadroxil—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00213	0.0395	CcSEcCtD
Cefadroxil—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00213	0.0395	CcSEcCtD
Cefadroxil—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00213	0.0395	CcSEcCtD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.0021	0.00709	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.0021	0.00709	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0021	0.00708	CbGpPWpGaD
Cefadroxil—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00208	0.0387	CcSEcCtD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00195	0.00658	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00195	0.00658	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00192	0.00647	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00192	0.00647	CbGpPWpGaD
Cefadroxil—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00191	0.0355	CcSEcCtD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0019	0.0064	CbGpPWpGaD
Cefadroxil—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0018	0.0335	CcSEcCtD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00174	0.00585	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00174	0.00585	CbGpPWpGaD
Cefadroxil—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.0017	0.0316	CcSEcCtD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00159	0.00537	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00159	0.00537	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00158	0.00534	CbGpPWpGaD
Cefadroxil—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00154	0.0287	CcSEcCtD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00148	0.005	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00148	0.005	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00148	0.00499	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00148	0.00499	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00145	0.00491	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00145	0.00491	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00145	0.00489	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00145	0.00489	CbGpPWpGaD
Cefadroxil—Tension—Hydrochlorothiazide—nephrolithiasis	0.0014	0.0259	CcSEcCtD
Cefadroxil—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00138	0.0257	CcSEcCtD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00137	0.00464	CbGpPWpGaD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00137	0.00464	CbGpPWpGaD
Cefadroxil—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00137	0.0254	CcSEcCtD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00135	0.00456	CbGpPWpGaD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00135	0.00456	CbGpPWpGaD
Cefadroxil—SLC15A2—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00132	0.00445	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00132	0.00444	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00132	0.00444	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00131	0.00442	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00131	0.00442	CbGpPWpGaD
Cefadroxil—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0013	0.0242	CcSEcCtD
Cefadroxil—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00128	0.0238	CcSEcCtD
Cefadroxil—SLC15A1—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00123	0.00413	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00122	0.00412	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00122	0.00412	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00122	0.0041	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00122	0.0041	CbGpPWpGaD
Cefadroxil—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00121	0.0225	CcSEcCtD
Cefadroxil—SLC22A5—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00121	0.00406	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.0012	0.00403	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.0012	0.00403	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00117	0.00394	CbGpPWpGaD
Cefadroxil—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00116	0.0216	CcSEcCtD
Cefadroxil—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00114	0.0211	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0011	0.0037	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0011	0.0037	CbGpPWpGaD
Cefadroxil—SLC22A8—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00109	0.00368	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00108	0.00366	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00108	0.00365	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00108	0.00365	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00107	0.0036	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00107	0.0036	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00107	0.0036	CbGpPWpGaD
Cefadroxil—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00106	0.0197	CcSEcCtD
Cefadroxil—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00103	0.0192	CcSEcCtD
Cefadroxil—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00102	0.019	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00102	0.00344	CbGpPWpGaD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00102	0.00344	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000992	0.00334	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000992	0.00334	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000975	0.00329	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000975	0.00329	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000964	0.00325	CbGpPWpGaD
Cefadroxil—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000949	0.0176	CcSEcCtD
Cefadroxil—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000922	0.0171	CcSEcCtD
Cefadroxil—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000917	0.0171	CcSEcCtD
Cefadroxil—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000917	0.0171	CcSEcCtD
Cefadroxil—SLC22A6—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00091	0.00307	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000903	0.00305	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000903	0.00305	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000882	0.00297	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000882	0.00297	CbGpPWpGaD
Cefadroxil—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000855	0.0159	CcSEcCtD
Cefadroxil—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000832	0.0155	CcSEcCtD
Cefadroxil—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000821	0.0153	CcSEcCtD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00081	0.00273	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00081	0.00273	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000805	0.00271	CbGpPWpGaD
Cefadroxil—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000794	0.0148	CcSEcCtD
Cefadroxil—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000767	0.0143	CcSEcCtD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000753	0.00254	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000753	0.00254	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000751	0.00253	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000751	0.00253	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000739	0.00249	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000739	0.00249	CbGpPWpGaD
Cefadroxil—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000738	0.0137	CcSEcCtD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000736	0.00248	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000736	0.00248	CbGpPWpGaD
Cefadroxil—Rash—Hydrochlorothiazide—nephrolithiasis	0.000732	0.0136	CcSEcCtD
Cefadroxil—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000731	0.0136	CcSEcCtD
Cefadroxil—Headache—Hydrochlorothiazide—nephrolithiasis	0.000727	0.0135	CcSEcCtD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000699	0.00236	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000699	0.00236	CbGpPWpGaD
Cefadroxil—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000689	0.0128	CcSEcCtD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000687	0.00232	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000687	0.00232	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000671	0.00226	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000671	0.00226	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000668	0.00225	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000668	0.00225	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000623	0.0021	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000623	0.0021	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000621	0.0021	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000621	0.0021	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000612	0.00207	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000612	0.00207	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000558	0.00188	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000558	0.00188	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000554	0.00187	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000554	0.00187	CbGpPWpGaD
Cefadroxil—SLC15A2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000536	0.00181	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000519	0.00175	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000519	0.00175	CbGpPWpGaD
Cefadroxil—SLC15A1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000498	0.00168	CbGpPWpGaD
Cefadroxil—SLC22A5—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00049	0.00165	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000462	0.00156	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000462	0.00156	CbGpPWpGaD
Cefadroxil—SLC22A8—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000443	0.00149	CbGpPWpGaD
Cefadroxil—SLC22A6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000369	0.00125	CbGpPWpGaD
